Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Risk of CVD”

106 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 106 results

Large-scale testing (Phase 3)Study completedNCT00501059
What this trial is testing

Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease

Who this might be right for
Moderate Risk of CVD
Bayer 12,546
Not applicableUnknownNCT01939080
What this trial is testing

Variation of Aortic Compliance Related to Exercise Training With or Without Supervised Sessions

Who this might be right for
Cardiovascular Disease
University Hospital Center of Martinique 308
Testing effectiveness (Phase 2)Study completedNCT00349765
What this trial is testing

Effects of Various Higher Fat and Lower Fat Snacks on Cardiovascular Risk Factors in Men and Women.

Who this might be right for
Hypercholesterolemia
University of Alabama at Birmingham 42
Post-approval studies (Phase 4)UnknownNCT01141153
What this trial is testing

Anticoagulation in Stent Intervention

Who this might be right for
Atrial FibrillationStroke
Hospital Universitari Vall d'Hebron Research Institute 304
Post-approval studies (Phase 4)Study completedNCT01331837
What this trial is testing

Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 3,080
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Study completedNCT00131144
What this trial is testing

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis 583
Not applicableUnknownNCT03344133
What this trial is testing

Effect of Exercise Programme on Gut Microbiota, CVD Risk Factors and Appetite Regulation in Overweight Women

Who this might be right for
Overweight and Obesity
University of Glasgow 60
Early research (Phase 1)Active Not RecruitingNCT01815749
What this trial is testing

Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+21 more
City of Hope Medical Center
Not applicableNot Yet RecruitingNCT07374718
What this trial is testing

Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk

Who this might be right for
Acute Coronary Syndrome (ACS)High Bleeding Risk(HBR)Coronary Artery Disease (CAD)
Shenyang Northern Hospital 468
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Early research (Phase 1)UnknownNCT04925050
What this trial is testing

First-in-Human Study of VB0004 in Healthy Subjects and to Patients With Mild to Moderate Hypertension With Low Cardiovascular Risk

Who this might be right for
Hypertension
Syneos Health 88
Large-scale testing (Phase 3)WithdrawnNCT02604238
What this trial is testing

Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism

Who this might be right for
Pulmonary Embolism
Azienda U.S.L. 1 di Massa e Carrara
Large-scale testing (Phase 3)Study completedNCT05439356
What this trial is testing

Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)

Who this might be right for
Ischemic StrokeTIA
Beijing Tiantan Hospital 8,343
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Not applicableStudy completedNCT03393377
What this trial is testing

Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination

Who this might be right for
Atherosclerosis
University Medical Centre Ljubljana 20
Not applicableStudy completedNCT01732419
What this trial is testing

Homebased Training With Telemonitoring Guidance in Low to Moderate Risk Patients Entering Cardiac Rehabilitation

Who this might be right for
Acute Coronary SyndromeMyocardial Infarction
Maxima Medical Center 90
Post-approval studies (Phase 4)Looking for participantsNCT03770312
What this trial is testing

Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-70 RCT Study

Who this might be right for
Healthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular Disease
Yonsei University 724
Large-scale testing (Phase 3)Study completedNCT00130845
What this trial is testing

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis 312
Not applicableStudy completedNCT00266435
What this trial is testing

The Usefulness of the HyperQ Stress System in Routine Annual Screening Testing

Who this might be right for
Cardiovascular Diseases
Sheba Medical Center 371
Next Page
30